インスリン グラルジンの世界および米国市場レポート&予測 2022-2028Global and United States Insulin Glargine Market Report & Forecast 2022-2028 インスリングラルギンは、ランタスなどの名称で販売されている長時間作用型の基礎インスリンアナログ製剤で、1日1回の投与で糖尿病患者の血糖値をコントロールすることができます。インスリンを徐放する微結晶か... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーインスリングラルギンは、ランタスなどの名称で販売されている長時間作用型の基礎インスリンアナログ製剤で、1日1回の投与で糖尿病患者の血糖値をコントロールすることができます。インスリンを徐放する微結晶からなり、18〜26時間の長い作用時間を持ち、「ピークレス」プロファイルを示します(インスリン グラルギンの添付文書による)。市場の分析と洞察。インスリン グラルジンの世界市場および米国市場 本レポートでは、世界と米国のインスリン グラルギン市場に焦点を当て、その他の地域の地域レベルおよび郡レベルのセグメントデータもカバーしています。 COVID-19の大流行により、世界のインスリン・グラルギン市場規模は2022年に6億7000万米ドル相当と推定され、レビュー期間中にCAGR4.0%で2028年までに8億4880万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、タイプ別では、2021年にインスリン・グラルギン世界市場の%を占めたプレフィルド注射が、2028年には百万米ドルの価値を持ち、ポストCOVID-19期間に修正された%のCAGRで成長すると予測されます。アプリケーション別では、1型糖尿病治療が主要セグメントで、2021年の市場シェアは%以上を占め、この予測期間を通して%CAGRに変更されました。 世界のインスリン グラルギンの主要企業は、Sanofi社、Eli Lilly社などです。世界の上位2社のシェアは50%近くを占めています。 最大の市場は米国で60%以上、次いで中国、欧州でいずれも35%程度のシェアとなっています。 製品別では、プレフィルドシリンジが最大のセグメントで、約75%のシェアを持っています。また、用途別では、2型糖尿病の治療薬が最も多く、次いで1型糖尿病の治療薬となっています。 インスリン グラルジンの世界的な範囲と市場規模 インスリン グラルギン市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のインスリン・グラルギン市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別の収益と予測に焦点を当て、2017年から2028年までの期間を分析します。 米国市場については、2017-2028年の期間、プレイヤー別、タイプ別、アプリケーション別のインスリン グラルギン市場規模に焦点を当てます。主要プレイヤーには、米国で重要な役割を果たすグローバルプレイヤーおよびローカルプレイヤーが含まれます。 タイプ別セグメント プレフィルドインジェクション ノンプレフィルドインジェクション 用途別セグメント 1型糖尿病治療薬 2型糖尿病治療剤 地域別 北アメリカ 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋地域 中国 日本 韓国 インド オーストラリア 中国 台湾 インドネシア タイ マレーシア 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア UAE 会社別 サノフィ Eli Lilly ビアトリス ガン&リー・ファーマシューティカルズ 東華東方製薬 ユナイテッド・ラボラトリーズ・インターナショナル 目次1 Study Coverage1.1 Insulin Glargine Product Introduction 1.2 Global Insulin Glargine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Insulin Glargine Sales in US$ Million for the Year 2017-2028 1.2.2 Global Insulin Glargine Sales in Volume for the Year 2017-2028 1.3 United States Insulin Glargine Outlook 2017 VS 2022 VS 2028 1.3.1 United States Insulin Glargine Sales in US$ Million for the Year 2017-2028 1.3.2 United States Insulin Glargine Sales in Volume for the Year 2017-2028 1.4 Insulin Glargine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Insulin Glargine in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Insulin Glargine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Insulin Glargine Market Dynamics 1.5.1 Insulin Glargine Industry Trends 1.5.2 Insulin Glargine Market Drivers 1.5.3 Insulin Glargine Market Challenges 1.5.4 Insulin Glargine Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Insulin Glargine Market Segment by Type 2.1.1 Prefilled Injection 2.1.2 Non-Prefilled Injection 2.2 Global Insulin Glargine Market Size by Type 2.2.1 Global Insulin Glargine Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Insulin Glargine Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Insulin Glargine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Insulin Glargine Market Size by Type 2.3.1 United States Insulin Glargine Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Insulin Glargine Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Insulin Glargine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Insulin Glargine Market Segment by Application 3.1.1 Type 1 Diabetes Treatment 3.1.2 Type 2 Diabetes Treatment 3.2 Global Insulin Glargine Market Size by Application 3.2.1 Global Insulin Glargine Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Insulin Glargine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Insulin Glargine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Insulin Glargine Market Size by Application 3.3.1 United States Insulin Glargine Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Insulin Glargine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Insulin Glargine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Insulin Glargine Competitor Landscape by Company 4.1 Global Insulin Glargine Market Size by Company 4.1.1 Top Global Insulin Glargine Manufacturers Ranked by Revenue (2021) 4.1.2 Global Insulin Glargine Revenue by Manufacturer (2017-2022) 4.1.3 Global Insulin Glargine Sales by Manufacturer (2017-2022) 4.1.4 Global Insulin Glargine Price by Manufacturer (2017-2022) 4.2 Global Insulin Glargine Concentration Ratio (CR) 4.2.1 Insulin Glargine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Insulin Glargine in 2021 4.2.3 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Insulin Glargine Manufacturing Base Distribution, Product Type 4.3.1 Global Insulin Glargine Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Insulin Glargine Product Type 4.3.3 Date of International Manufacturers Enter into Insulin Glargine Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Insulin Glargine Market Size by Company 4.5.1 Top Insulin Glargine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Insulin Glargine Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Insulin Glargine Sales by Players (2020, 2021 & 2022) 5 Global Insulin Glargine Market Size by Region 5.1 Global Insulin Glargine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Insulin Glargine Market Size in Volume by Region (2017-2028) 5.2.1 Global Insulin Glargine Sales in Volume by Region: 2017-2022 5.2.2 Global Insulin Glargine Sales in Volume Forecast by Region (2023-2028) 5.3 Global Insulin Glargine Market Size in Value by Region (2017-2028) 5.3.1 Global Insulin Glargine Sales in Value by Region: 2017-2022 5.3.2 Global Insulin Glargine Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Insulin Glargine Market Size YoY Growth 2017-2028 6.1.2 North America Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Insulin Glargine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Insulin Glargine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Insulin Glargine Market Size YoY Growth 2017-2028 6.3.2 Europe Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Insulin Glargine Market Size YoY Growth 2017-2028 6.4.2 Latin America Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Insulin Glargine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Sanofi 7.1.1 Sanofi Corporation Information 7.1.2 Sanofi Description and Business Overview 7.1.3 Sanofi Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Sanofi Insulin Glargine Products Offered 7.1.5 Sanofi Recent Development 7.2 Eli Lilly 7.2.1 Eli Lilly Corporation Information 7.2.2 Eli Lilly Description and Business Overview 7.2.3 Eli Lilly Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Eli Lilly Insulin Glargine Products Offered 7.2.5 Eli Lilly Recent Development 7.3 Viatris 7.3.1 Viatris Corporation Information 7.3.2 Viatris Description and Business Overview 7.3.3 Viatris Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Viatris Insulin Glargine Products Offered 7.3.5 Viatris Recent Development 7.4 Gan&Lee Pharmaceuticals 7.4.1 Gan&Lee Pharmaceuticals Corporation Information 7.4.2 Gan&Lee Pharmaceuticals Description and Business Overview 7.4.3 Gan&Lee Pharmaceuticals Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Gan&Lee Pharmaceuticals Insulin Glargine Products Offered 7.4.5 Gan&Lee Pharmaceuticals Recent Development 7.5 Tonghua Dongbao Pharmaceutical 7.5.1 Tonghua Dongbao Pharmaceutical Corporation Information 7.5.2 Tonghua Dongbao Pharmaceutical Description and Business Overview 7.5.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Products Offered 7.5.5 Tonghua Dongbao Pharmaceutical Recent Development 7.6 United Laboratories International 7.6.1 United Laboratories International Corporation Information 7.6.2 United Laboratories International Description and Business Overview 7.6.3 United Laboratories International Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.6.4 United Laboratories International Insulin Glargine Products Offered 7.6.5 United Laboratories International Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Insulin Glargine Industry Chain Analysis 8.2 Insulin Glargine Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Insulin Glargine Distributors 8.3 Insulin Glargine Production Mode & Process 8.4 Insulin Glargine Sales and Marketing 8.4.1 Insulin Glargine Sales Channels 8.4.2 Insulin Glargine Distributors 8.5 Insulin Glargine Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryInsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Table of Contents1 Study Coverage1.1 Insulin Glargine Product Introduction 1.2 Global Insulin Glargine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Insulin Glargine Sales in US$ Million for the Year 2017-2028 1.2.2 Global Insulin Glargine Sales in Volume for the Year 2017-2028 1.3 United States Insulin Glargine Outlook 2017 VS 2022 VS 2028 1.3.1 United States Insulin Glargine Sales in US$ Million for the Year 2017-2028 1.3.2 United States Insulin Glargine Sales in Volume for the Year 2017-2028 1.4 Insulin Glargine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Insulin Glargine in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Insulin Glargine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Insulin Glargine Market Dynamics 1.5.1 Insulin Glargine Industry Trends 1.5.2 Insulin Glargine Market Drivers 1.5.3 Insulin Glargine Market Challenges 1.5.4 Insulin Glargine Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Insulin Glargine Market Segment by Type 2.1.1 Prefilled Injection 2.1.2 Non-Prefilled Injection 2.2 Global Insulin Glargine Market Size by Type 2.2.1 Global Insulin Glargine Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Insulin Glargine Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Insulin Glargine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Insulin Glargine Market Size by Type 2.3.1 United States Insulin Glargine Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Insulin Glargine Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Insulin Glargine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Insulin Glargine Market Segment by Application 3.1.1 Type 1 Diabetes Treatment 3.1.2 Type 2 Diabetes Treatment 3.2 Global Insulin Glargine Market Size by Application 3.2.1 Global Insulin Glargine Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Insulin Glargine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Insulin Glargine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Insulin Glargine Market Size by Application 3.3.1 United States Insulin Glargine Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Insulin Glargine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Insulin Glargine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Insulin Glargine Competitor Landscape by Company 4.1 Global Insulin Glargine Market Size by Company 4.1.1 Top Global Insulin Glargine Manufacturers Ranked by Revenue (2021) 4.1.2 Global Insulin Glargine Revenue by Manufacturer (2017-2022) 4.1.3 Global Insulin Glargine Sales by Manufacturer (2017-2022) 4.1.4 Global Insulin Glargine Price by Manufacturer (2017-2022) 4.2 Global Insulin Glargine Concentration Ratio (CR) 4.2.1 Insulin Glargine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Insulin Glargine in 2021 4.2.3 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Insulin Glargine Manufacturing Base Distribution, Product Type 4.3.1 Global Insulin Glargine Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Insulin Glargine Product Type 4.3.3 Date of International Manufacturers Enter into Insulin Glargine Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Insulin Glargine Market Size by Company 4.5.1 Top Insulin Glargine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Insulin Glargine Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Insulin Glargine Sales by Players (2020, 2021 & 2022) 5 Global Insulin Glargine Market Size by Region 5.1 Global Insulin Glargine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Insulin Glargine Market Size in Volume by Region (2017-2028) 5.2.1 Global Insulin Glargine Sales in Volume by Region: 2017-2022 5.2.2 Global Insulin Glargine Sales in Volume Forecast by Region (2023-2028) 5.3 Global Insulin Glargine Market Size in Value by Region (2017-2028) 5.3.1 Global Insulin Glargine Sales in Value by Region: 2017-2022 5.3.2 Global Insulin Glargine Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Insulin Glargine Market Size YoY Growth 2017-2028 6.1.2 North America Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Insulin Glargine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Insulin Glargine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Insulin Glargine Market Size YoY Growth 2017-2028 6.3.2 Europe Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Insulin Glargine Market Size YoY Growth 2017-2028 6.4.2 Latin America Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Insulin Glargine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Insulin Glargine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Sanofi 7.1.1 Sanofi Corporation Information 7.1.2 Sanofi Description and Business Overview 7.1.3 Sanofi Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Sanofi Insulin Glargine Products Offered 7.1.5 Sanofi Recent Development 7.2 Eli Lilly 7.2.1 Eli Lilly Corporation Information 7.2.2 Eli Lilly Description and Business Overview 7.2.3 Eli Lilly Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Eli Lilly Insulin Glargine Products Offered 7.2.5 Eli Lilly Recent Development 7.3 Viatris 7.3.1 Viatris Corporation Information 7.3.2 Viatris Description and Business Overview 7.3.3 Viatris Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Viatris Insulin Glargine Products Offered 7.3.5 Viatris Recent Development 7.4 Gan&Lee Pharmaceuticals 7.4.1 Gan&Lee Pharmaceuticals Corporation Information 7.4.2 Gan&Lee Pharmaceuticals Description and Business Overview 7.4.3 Gan&Lee Pharmaceuticals Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Gan&Lee Pharmaceuticals Insulin Glargine Products Offered 7.4.5 Gan&Lee Pharmaceuticals Recent Development 7.5 Tonghua Dongbao Pharmaceutical 7.5.1 Tonghua Dongbao Pharmaceutical Corporation Information 7.5.2 Tonghua Dongbao Pharmaceutical Description and Business Overview 7.5.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Products Offered 7.5.5 Tonghua Dongbao Pharmaceutical Recent Development 7.6 United Laboratories International 7.6.1 United Laboratories International Corporation Information 7.6.2 United Laboratories International Description and Business Overview 7.6.3 United Laboratories International Insulin Glargine Sales, Revenue and Gross Margin (2017-2022) 7.6.4 United Laboratories International Insulin Glargine Products Offered 7.6.5 United Laboratories International Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Insulin Glargine Industry Chain Analysis 8.2 Insulin Glargine Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Insulin Glargine Distributors 8.3 Insulin Glargine Production Mode & Process 8.4 Insulin Glargine Sales and Marketing 8.4.1 Insulin Glargine Sales Channels 8.4.2 Insulin Glargine Distributors 8.5 Insulin Glargine Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(生化学的薬物)の最新刊レポートQYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(insulin)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |